Low disease activity in psoriatic arthritis: a cross-sectional analysis of a cohort of patients with Psoriatic Arthritis

Low disease activity in psoriatic arthritis: a cross-sectional analysis of a cohort of patients with Psoriatic Arthritis - LDA in PsA

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON39993

Enrollment

250

Registered

2012-12-12

Start date

2013-02-16

Completion date

Unknown

Last updated

2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

psoriatic arthritis spondyloarthritis

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: psoriatic arthritis en voldoen aan classificatie criteria for psoriatic arthritis (CASPAR) low disease activity according to rheumatologist no matter what therapy

Exclusion criteria

Exclusion criteria: concomittant rheumatic diseases other than psoriatic arthritis other painful conditions that may interfere the disease activiity evaluations

Design outcomes

Primary

Measure	Time frame
- Disease activity will be assessed in all potential disease domains. - The proportion of patients that fulfills the criteria for Minimal Disease Activity (MDA) will be determined. - The proportion of patients that fulfills the criteria for MDA in DMARD treated versus TNFi treated patients. - Current medication (type, dosage and start date) will be documented	—

Secondary

Measure	Time frame
- Parameters related to cardiovascular outcomes will be assessed. - Depression, quality of life, and work participation. - Determination of biomarkers and genetic markers	—

Countries

Netherlands

Outcome results